drugset / Trial / NCT06389942
Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject
RandomizedSequentialDouble-blindTreatment
Summary
The objectives of the study are to evaluate the safety , tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single ascending intravenous (IV) doses of 9MW3011 in Chinese healthy volunteers.
Timeline
- Start
- 2023-03-10
- Primary completion
- 2024-05-31
- Completion
- 2024-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 9MW3011 | Unknown | — | Intravenous |
Indications
No indication recorded.